What is she best known for?
The fields of study she is best known for:
Joyce Taylor-Papadimitriou mostly deals with Molecular biology, Antibody, Mucin, Monoclonal antibody and Epitope.
Her Molecular biology research includes elements of Glycosylation, Complementary DNA, Gene, MUC1 and Tandem repeat.
Joyce Taylor-Papadimitriou combines subjects such as Breast cancer, Antigen and Keratin with her study of Antibody.
In her research, Vimentin, In vitro, Hepatocyte growth factor, Integrin alpha3beta1 and Integrin is intimately related to Cell culture, which falls under the overarching field of Mucin.
The concepts of her Monoclonal antibody study are interwoven with issues in Epithelium, Pathology, Polyclonal antibodies and Advanced disease.
Joyce Taylor-Papadimitriou has included themes like Humoral immunity, Peptide sequence, Cancer research and Adenocarcinoma in her Epitope study.
Her most cited work include:
- Molecular cloning and expression of human Tumor-associated Polymorphic Epithelial Mucin (912 citations)
- Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. (546 citations)
- A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. (523 citations)
What are the main themes of her work throughout her whole career to date?
Joyce Taylor-Papadimitriou spends much of her time researching Molecular biology, Antibody, MUC1, Mucin and Antigen.
Her studies deal with areas such as Cell culture, Biochemistry, Gene and Interferon as well as Molecular biology.
Her is doing research in Monoclonal antibody and Epitope, both of which are found in Antibody.
As a member of one scientific family, she mostly works in the field of Monoclonal antibody, focusing on Pathology and, on occasion, Scintigraphy.
Her MUC1 research incorporates elements of Glycosylation and Tandem repeat.
Her studies in Immunology integrate themes in fields like Cancer research and Cell biology.
She most often published in these fields:
- Molecular biology (42.58%)
- Antibody (26.17%)
- MUC1 (20.70%)
What were the highlights of her more recent work (between 2006-2021)?
- Cancer research (18.36%)
- Molecular biology (42.58%)
- MUC1 (20.70%)
In recent papers she was focusing on the following fields of study:
Joyce Taylor-Papadimitriou focuses on Cancer research, Molecular biology, MUC1, Glycosylation and Antibody.
Her Cancer research research incorporates elements of Breast cancer and Mammary gland.
Her research in Molecular biology intersects with topics in Repressor, Gene, Monoclonal antibody and Antigen.
In the field of Mucin and Cancer she studies MUC1.
Her study in Glycosylation is interdisciplinary in nature, drawing from both Gene expression, Glycosyltransferase, Glycan, Cell biology and Selectin.
Her Antibody research is classified as research in Immunology.
Between 2006 and 2021, her most popular works were:
- PLU-1 Is an H3K4 Demethylase Involved in Transcriptional Repression and Breast Cancer Cell Proliferation (391 citations)
- Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells (270 citations)
- Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor. (229 citations)
In her most recent research, the most cited papers focused on:
Her main research concerns Molecular biology, MUC1, Glycosylation, Antibody and Cell biology.
Her Molecular biology research incorporates themes from Promoter, Gene and Repressor.
Her MUC1 study contributes to a more complete understanding of Antigen.
As part of the same scientific family, Joyce Taylor-Papadimitriou usually focuses on Glycosylation, concentrating on Mucin and intersecting with SIGLEC, Cancer cell, Tumor microenvironment and Calcium flux.
Her Epitope and Isotype study in the realm of Antibody interacts with subjects such as Glycopeptide.
Her Epitope research is multidisciplinary, incorporating perspectives in Humoral immunity, Monoclonal antibody, Tandem repeat and Polyclonal antibodies.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
